ArticleInternational journal of medical sciences2022

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic.

Yasuhito Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.